• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度分离株中新型冠状病毒核衣壳磷蛋白变体的分子评估

The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates.

作者信息

Azad Gajendra Kumar

机构信息

Department of Zoology, Patna University, Patna, 800005, Bihar, India.

出版信息

Heliyon. 2021 Feb;7(2):e06167. doi: 10.1016/j.heliyon.2021.e06167. Epub 2021 Feb 1.

DOI:10.1016/j.heliyon.2021.e06167
PMID:33553784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7848562/
Abstract

Coronavirus disease- 2019 (COVID-19) has rapidly become a major threat to humans due to its high infection rate and deaths caused worldwide. This disease is caused by an RNA virus, Severe Acquired Respiratory Syndrome -Corona Virus-2 (SARS-CoV-2). This class of viruses have a high rate of mutation than DNA viruses that enables them to adapt and also evade host immune system. Here, we compared the first known Nucleocapsid Phosphoprotein (N protein) sequence of SARS-CoV-2 from China with the sequences from Indian COVID-19 patients to understand, if this virus is also mutating, as it is spreading to new locations. Our data revealed twenty mutations present among Indian isolates. Out of these, mutation at six positions led to changes in the secondary structure of N protein. Further, we also show that these mutations are primarily destabilising the protein structure. The candidate mutations identified in this study may help to speed up the understanding of variations occurring in SARS-CoV-2.

摘要

2019冠状病毒病(COVID-19)因其高感染率和在全球范围内造成的死亡人数,迅速成为对人类的重大威胁。这种疾病由一种RNA病毒——严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起。这类病毒的突变率高于DNA病毒,这使它们能够适应并逃避免疫系统。在此,我们将中国首次发现的SARS-CoV-2核衣壳磷蛋白(N蛋白)序列与印度COVID-19患者的序列进行比较,以了解这种病毒在传播到新地区时是否也在发生突变。我们的数据显示,印度分离株中有20个突变。其中,六个位置的突变导致了N蛋白二级结构的变化。此外,我们还表明,这些突变主要使蛋白质结构不稳定。本研究中确定的候选突变可能有助于加快对SARS-CoV-2中发生变异的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/8c35ed81f1c2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/49c7f5ad91e9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/88def40005c4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/e94d089885d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/8c35ed81f1c2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/49c7f5ad91e9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/88def40005c4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/e94d089885d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f9/7887406/8c35ed81f1c2/gr4.jpg

相似文献

1
The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates.印度分离株中新型冠状病毒核衣壳磷蛋白变体的分子评估
Heliyon. 2021 Feb;7(2):e06167. doi: 10.1016/j.heliyon.2021.e06167. Epub 2021 Feb 1.
2
Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.来自不同国家的新型冠状病毒(SARS-CoV-2)分离株的结构蛋白和开放阅读框8蛋白的基因特征分析
Gene Rep. 2020 Dec;21:100886. doi: 10.1016/j.genrep.2020.100886. Epub 2020 Sep 14.
3
Immunoinformatics Study of SARS-CoV-2 Nucleocapsid Phosphoprotein Identifies Promising Epitopes with Mutational Implications.严重急性呼吸综合征冠状病毒2核衣壳磷蛋白的免疫信息学研究确定了具有突变影响的有前景的表位。
Moscow Univ Biol Sci Bull. 2022;77(4):251-257. doi: 10.3103/S0096392522040125. Epub 2023 Feb 20.
4
Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.印度出现的 SARS-CoV-2 分离株的基因组分析:现状。
Indian J Public Health. 2020 Jun;64(Supplement):S147-S155. doi: 10.4103/ijph.IJPH_506_20.
5
A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics.印度新冠病毒毒株对当代复发性抗病毒疗法的一种劫持机制。
Comput Biol Med. 2021 May;132:104315. doi: 10.1016/j.compbiomed.2021.104315. Epub 2021 Mar 6.
6
Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.新型冠状病毒核衣壳磷蛋白突变的鉴定与分子特征分析
PeerJ. 2021 Jan 4;9:e10666. doi: 10.7717/peerj.10666. eCollection 2021.
7
Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.鉴定和分析 SARS-CoV-2 依赖 RNA 的 RNA 聚合酶的突变,作为一种有前景的抗病毒治疗靶点。
Arch Microbiol. 2021 Nov;203(9):5463-5473. doi: 10.1007/s00203-021-02527-9. Epub 2021 Aug 19.
8
Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.SARS-CoV-2 核衣壳磷酸蛋白中的独特纤维蛋白原结合基序:在宿主-病原体相互作用中的潜在意义。
Med Hypotheses. 2020 Nov;144:110030. doi: 10.1016/j.mehy.2020.110030. Epub 2020 Jun 24.
9
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
10
Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.对来自印度分离株的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白中的基因组变异和突变进行特征分析。
Gene Rep. 2021 Dec;25:101044. doi: 10.1016/j.genrep.2021.101044. Epub 2021 Feb 19.

引用本文的文献

1
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy.意大利三次疫情浪潮期间空军机场军事和文职人员中新型冠状病毒变异株的特征分析
Microorganisms. 2023 Nov 5;11(11):2711. doi: 10.3390/microorganisms11112711.
2
A computational study on mitogenome-encoded proteins of Pavo cristatus and Pavo muticus identifies key genetic variations with functional implications.孔雀和绿孔雀线粒体基因组编码蛋白的计算研究确定了具有功能影响的关键遗传变异。
J Genet Eng Biotechnol. 2023 Aug 7;21(1):80. doi: 10.1186/s43141-023-00534-5.
3
An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13.

本文引用的文献

1
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.通过联合虚拟筛选和监督机器学习鉴定针对 SARS-CoV-2 冠状病毒三个靶点的新型化合物。
Comput Biol Med. 2021 Jun;133:104359. doi: 10.1016/j.compbiomed.2021.104359. Epub 2021 Mar 30.
2
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.对 3067 个 SARS-CoV-2 基因组的大规模基因组分析揭示了克隆的地理分布和热点突变的丰富遗传变异。
PLoS One. 2020 Nov 10;15(11):e0240345. doi: 10.1371/journal.pone.0240345. eCollection 2020.
3
一种研究严重急性呼吸综合征冠状病毒2解旋酶Nsp13表位的免疫信息学方法。
Vacunas. 2023 Mar 2. doi: 10.1016/j.vacun.2023.02.001.
4
Exploring the Immunodominant Epitopes of SARS-CoV-2 Nucleocapsid Protein as Exposure Biomarker.探索新冠病毒核衣壳蛋白的免疫显性表位作为暴露生物标志物
Cureus. 2023 Feb 10;15(2):e34827. doi: 10.7759/cureus.34827. eCollection 2023 Feb.
5
Immunoinformatics Study of SARS-CoV-2 Nucleocapsid Phosphoprotein Identifies Promising Epitopes with Mutational Implications.严重急性呼吸综合征冠状病毒2核衣壳磷蛋白的免疫信息学研究确定了具有突变影响的有前景的表位。
Moscow Univ Biol Sci Bull. 2022;77(4):251-257. doi: 10.3103/S0096392522040125. Epub 2023 Feb 20.
6
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔和奥密克戎变体:我们目前所了解的情况。
Vaccines (Basel). 2022 Nov 14;10(11):1926. doi: 10.3390/vaccines10111926.
7
Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein.严重急性呼吸综合征冠状病毒2核衣壳蛋白结构与组装的可塑性
PNAS Nexus. 2022 May 16;1(2):pgac049. doi: 10.1093/pnasnexus/pgac049. eCollection 2022 May.
8
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern.严重急性呼吸综合征冠状病毒2:五种值得关注的变异株的基因概况及疫苗有效性概述
Pathogens. 2022 Apr 26;11(5):516. doi: 10.3390/pathogens11050516.
9
Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein.基于结构的新型靶向 SARS-CoV-2 核衣壳蛋白人源抗体亲和力成熟。
Sci Rep. 2022 May 19;12(1):8469. doi: 10.1038/s41598-022-12242-0.
10
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变及其对诊断、治疗和疫苗的影响。
Front Med (Lausanne). 2022 Feb 22;9:815389. doi: 10.3389/fmed.2022.815389. eCollection 2022.
Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
新型冠状病毒(SARS-CoV-2)甲基转移酶复合物(Nsp10-Nsp16)中新型突变的鉴定
Biochem Biophys Rep. 2020 Dec;24:100833. doi: 10.1016/j.bbrep.2020.100833. Epub 2020 Oct 10.
4
Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.印度分离株中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)表面糖蛋白(刺突蛋白)的25个突变鉴定及其对蛋白质动力学的影响。
Gene Rep. 2020 Dec;21:100891. doi: 10.1016/j.genrep.2020.100891. Epub 2020 Sep 28.
5
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.新型冠状病毒(SARS-CoV-2)RNA依赖的RNA聚合酶中新型突变的鉴定及其对其蛋白质结构的影响。
PeerJ. 2020 Jul 3;8:e9492. doi: 10.7717/peerj.9492. eCollection 2020.
6
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.严重急性呼吸综合征冠状病毒2核衣壳蛋白RNA结合结构域的晶体结构揭示了潜在的独特药物靶向位点。
Acta Pharm Sin B. 2020 Jul;10(7):1228-1238. doi: 10.1016/j.apsb.2020.04.009. Epub 2020 Apr 20.
7
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.新兴的 SARS-CoV-2 突变热点包括一种新型 RNA 依赖性 RNA 聚合酶变体。
J Transl Med. 2020 Apr 22;18(1):179. doi: 10.1186/s12967-020-02344-6.
8
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
9
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
10
The EMBL-EBI search and sequence analysis tools APIs in 2019.2019 年的 EMBL-EBI 搜索和序列分析工具 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641. doi: 10.1093/nar/gkz268.